Department of Oncology, Tom Baker Cancer Centre, University of Calgary, Calgary, AB T2N 1N4, Canada.
Department of Family Medicine, University of Michigan, Ann Arbor, MI 48109, USA.
Curr Oncol. 2021 Feb 10;28(1):853-862. doi: 10.3390/curroncol28010084.
A growing number of cancer patients use complementary and alternative therapies during and after conventional cancer treatment. Patients are often reluctant to discuss these therapies with their oncologist, and oncologists may have limited knowledge and confidence on how to advise patients on the appropriate use. Integrative oncology is a patient-centered, evidence-informed field that utilizes mind-body practices, lifestyle modifications and/or natural products interwoven with conventional cancer treatment. It prioritizes safety and best available evidence to offer appropriate interventions alongside conventional care. There are few opportunities for oncologists to learn about integrative oncology. In this commentary, we highlight the Integrative Oncology Scholars (IOS) program as a means to increase competency in this growing field. We provide an overview of several integrative oncology modalities that are taught through this program, including lifestyle modifications, physical activity, and mind-body interventions. We conclude that as more evidence is generated in this field, it will be essential that oncology healthcare providers are aware of the prevalent use of these modalities by their patients and cancer centers include Integrative Oncology trained physicians and other healthcare professionals in their team to discuss and recommend evidence-based integrative oncology therapies alongside conventional cancer treatments to their patients.
越来越多的癌症患者在接受常规癌症治疗期间和之后会选择使用补充和替代疗法。患者通常不愿意与肿瘤医生讨论这些疗法,而肿瘤医生在如何就适当使用这些疗法为患者提供建议方面可能知之甚少且信心有限。整合肿瘤学是以患者为中心、以证据为基础的领域,它将身心实践、生活方式改变和/或天然产品与常规癌症治疗相结合。它优先考虑安全性和最佳现有证据,以便在常规护理的基础上提供适当的干预措施。肿瘤医生很少有机会学习整合肿瘤学。在这篇评论中,我们强调了整合肿瘤学学者 (IOS) 计划,以此作为提高该不断发展领域能力的一种手段。我们概述了通过该计划教授的几种整合肿瘤学模式,包括生活方式改变、身体活动和身心干预。我们得出的结论是,随着该领域产生更多的证据,肿瘤学医疗保健提供者必须意识到患者普遍使用这些模式,并且癌症中心应在其团队中包括接受过整合肿瘤学培训的医生和其他医疗保健专业人员,以便与常规癌症治疗一起讨论和推荐基于证据的整合肿瘤学疗法。
Curr Oncol. 2021-2-10
J Oncol Pract. 2019-1
J Altern Complement Med. 2018
Am Soc Clin Oncol Educ Book. 2023-5
J Altern Complement Med. 2018
J Natl Cancer Inst Monogr. 2017-11-1
CA Cancer J Clin. 2022-3
Curr Oncol Rep. 2023-6
Curr Oncol Rep. 2024-3
BMC Complement Altern Med. 2018-10-29
Curr Oncol. 2023-2-1
Int J Environ Res Public Health. 2022-4-8
CA Cancer J Clin. 2020-6-9
J Altern Complement Med. 2018